COX‐2 selective non‐steroidal anti‐inflammatory drugs and cardiovascular disease

This publication has 19 references indexed in Scilit:

• The safety of drugs for OTC use: what evidence is required for an NSAID switch?
  Pharmacoepidemiology and Drug Safety, 2002
• The Disputed Role of COX-2 in Myocardial Infarction, Is the Jury Still Out?
  Journal of Molecular and Cellular Cardiology, 2002
• Non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease: an observational cohort study
  The Lancet, 2002
• Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid Arthritis
  New England Journal of Medicine, 2000
• Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid Arthritis
  JAMA, 2000
• Consumption of NSAIDs and the Development of Congestive Heart Failure in Elderly Patients
  Archives of internal medicine (1960), 2000
• Identification of vascular endothelial genes differentially responsive to fluid mechanical stimuli: cyclooxygenase-2, manganese superoxide dismutase, and endothelial cell nitric oxide synthase are selectively up-regulated by steady laminar shear stress.
  Proceedings of the National Academy of Sciences, 1996
• Role of a nonsteroidal anti-inflammatory agent, ibuprofen, in coronary revascularization after acute myocardial infarction
  Basic Research in Cardiology, 1990
• Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides.
  Proceedings of the National Academy of Sciences, 1975